|
|
Research on the value of Conjugated Estrogen Cream combined with Misoprostol in ring removal after menopause |
ZHOU Juan-juan |
Department of Obstetrics and Gynecology,Xishan People′s Hospital,Jiangsu Province,Wuxi 214105,China |
|
|
Abstract Objective To analyze the value of Conjugated Estrogen Cream combined with Misoprostol in ring removal after menopause.Methods A total of 80 postmenopausal patients who were treated in Xishan People′s Hospital from January 2017 to January 2020 were divided into control group(n=40)and observation group(n=40)according to random number table method.The control group were given Misoprostol 400 μg anal plug 1 h before operation,and the observation group was given 1 g of Conjugated Estregen Cream for vaginal medication for 1 week every day,and Misoprostol 400 μg anal plug 1 hour before operation.The visual analogue scores of the intraoperative dilation process,intraoperative blood loss,time of ring removal,total effective rate of cervical dilation,success rate of ring removal,and adverse reactions were compared between the two groups.Results The visual simulation score of intraoperative dilation of the observation group was lower than that of the control group,the amount of intraoperative blood loss was less than that of the control group,and the ring removal time was shorter than that of the control group,the differences were statistically significant(P<0.05).The total effective rate of cervical dilation and the success rate of ring removal were higher than those of the control group,the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Conjugated Estrogen Cream combined with Misoprostol has a high value in the application of postmenopausal ring removal.Conjugated Estrogen Cream is simple and convenient for vaginal administration,and the amount of Estrogen is small.It can effectively dilate the cervix,shorten the time of ring removal,reduce bleeding and improve the success rate of ring removal,and alleviate the pain of patients,which is worthy of promotion.
|
|
|
|
|
[1] |
郗玉丹.绝经后取环术前应用米非司酮的效果观察[J].中国城乡企业卫生,2020,35(4):70-72.
|
[2] |
乐杰.妇产科学[M].7版.北京:人民卫生出版社,2010:364.
|
[3] |
冯淑燕.230例床边超声引导联合米菲司酮、利多卡因用于绝经后取环效果分析[J].海峡预防医学杂志,2019,25(6):104-105.
|
[4] |
李敏.对接受取环术的绝经后女性用米非司酮、米索前列醇联合盐酸利多卡因进行辅助治疗的效果[J].当代医药论丛,2019,17(24):88-89.
|
[5] |
Cihangir U,Ebru A,Murat E,et al.Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding[J].Int J Gynaecol Obstet,2013,123(2):146-149.
|
[6] |
赵彩云.间苯三酚用于绝经后取环术的临床分析[J].中国继续医学教育,2019,11(32):147-149.
|
[7] |
王艳萍.米非司酮配伍米索前列醇用于绝经后取环术中的效果探讨[J].中国现代药 物应用,2019,13(21):174-175.
|
[8] |
黄丽.间苯三酚联合盐酸曲马多缓释片在绝经后取环术中的应用效果[J].中国当代医药,2019,26(29):122-124.
|
[9] |
张琦,张敏,张波.绝经后取环应用雌三醇软膏配合卡前列甲酯栓的可行性研究[J].中国农村卫生,2019,11(8):96.
|
[10] |
Lathrop E,Handdad L,McWhorter CP,et al.Self-administration of misoprostol ptior to intrauterine device insertion among nulliparous women:a randomized controlled trial[J].Contraception,2013,88(6):725-729.
|
[11] |
王源湘.米非司醇、米索前列醇在绝经后取环困难患者术前的应用效果分析[J].中国社区医师,2019,35(35):76-77.
|
[12] |
李彩红.绝经后取环困难术前应用米非司酮、米索的临床疗效分析[J].数理医药学杂志,2019,32(2):239-240.
|
[13] |
温新兰.米非司酮配伍利多卡因绝经后取环术的应用和体会[J].中国农村卫生,2019,11(3):48-49.
|
[14] |
王玉华.宫腔镜联合B超用于宫内节育器取出困难的治疗体会[J].滨州医学院学报,2019,42(6):464-466.
|
[15] |
何品姝.米索前列醇联合戊酸雌二醇用于绝经后妇女取环的效果观察[J].临床合理用药杂志,2018,11(31):91-92.
|
[16] |
张丽梅.米非司酮联合米索前列醇在绝经妇女取环术中的应用效果[J].心理医生,2019,25(6):30-31.
|
[17] |
沙吾列西·吐尔达洪.探讨在绝经后妇女取环中采用补佳乐联合米索前列醇及利多卡因的效果[J].实用妇科内分泌电子杂志,2019,6(33):120.
|
[18] |
任红伟,王艳,张玉香,等.间苯三酚联合戊酸雌二醇在绝经后妇女取环中的临床应用[J].临床和实验医学杂志,2020,19(9):998-1000.
|
[19] |
张守娥,杨美玉.米索前列醇联合盐酸奥布卡因凝胶用于绝经后取环的效果观察[J].临床医药实践,2020,29(1):42-44.
|
|
|
|